Form D · Pharmaceuticals

XANODYNE PHARMACEUTICALS INC

Newport, KY · CIK 0001335480

Offering snapshot reported Oct 30, 2009 · SEC filing

Reported sold
$87.8M
Offering amount: $87.8M
Investors reported
35
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 15, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$43.9M$87.8MMay 21, 2009: $37,783,864.00May 21, 2009Oct 30, 2009: $87,783,861.00Oct 30, 2009

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$37,783,864 → $87,783,861

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 30, 2009Amendment$87,783,861$49,999,997vs May 21, 200935SEC filing
Oct 5, 2009InitialYet to sellNo comparison0SEC filing
May 21, 2009Initial$37,783,864No comparisonNot reportedSEC filing
Jul 5, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Sep 2, 2005PaperNot reportedNo comparisonNot reportedSEC filing
Aug 4, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$1.11M
Finders' fees
$0
Form D file number
021-79890

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Aquilo Partners, L.P.114909

Source: Form D, filed Oct 30, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kevin T. Anderson Executive
Timothy Arendt Executive
Rolf A. Classon Director
Daniel W. Docherty Executive
Patrick Enright Director
Natasha Giordano Executive
Thomas P. Jennings Executive
Vaughan M. Kailian Director
Vaughn M. Kailian Director
Rita M. O'connor Executive
Dennis Purcell Director
Gary A. Shangold Executive
James Shannon Director
Stephen A. Stamp Executive
Steven St. Peter Director
Stephen St. Peter Director
Craig Tooman Director
Michael Valentino Director, Executive
Peter Wentworth Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
One Riverfront Place
Newport, KY, 41071